Cargando…
Immune cells transcriptome-based drug repositioning for multiple sclerosis
OBJECTIVE: Finding target genes and target pathways of existing drugs for drug repositioning in multiple sclerosis (MS) based on transcriptomic changes in MS immune cells. MATERIALS AND METHODS: Based on transcriptome data from Gene Expression Omnibus (GEO) database, differentially expressed genes (...
Autores principales: | Yin, Xinyue, Rang, Xinming, Hong, Xiangxiang, Zhou, Yinglian, Xu, Chaohan, Fu, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630342/ https://www.ncbi.nlm.nih.gov/pubmed/36341423 http://dx.doi.org/10.3389/fimmu.2022.1020721 |
Ejemplares similares
-
The Shared Mechanism and Candidate Drugs of Multiple Sclerosis and Sjögren’s Syndrome Analyzed by Bioinformatics Based on GWAS and Transcriptome Data
por: Hong, Xiangxiang, et al.
Publicado: (2022) -
Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019) -
Combining Human Genetics of Multiple Sclerosis with Oxidative Stress Phenotype for Drug Repositioning
por: Olla, Stefania, et al.
Publicado: (2021) -
The emerging roles of piezo1 channels in animal models of multiple sclerosis
por: Yang, Kai, et al.
Publicado: (2022) -
CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis
por: Sinha, Sushmita, et al.
Publicado: (2015)